NRC Health reports Q2 2026 results with non-GAAP EPS $0.31 and revenue $35.4M, beats estimates
- Q2 2026 GAAP net loss totaled $3.3M, contrasting with positive non-GAAP EPS performance
- Company declared a quarterly cash dividend of $0.16 per share for shareholders
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.